What companies are REGN's competitors?

Regeneron Pharmaceuticals, Inc. (REGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does REGN compare to its peers?

The peer comparison table on this page shows Regeneron Pharmaceuticals, Inc. (REGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does REGN operate in?

Regeneron Pharmaceuticals, Inc. (REGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

REGN

Regeneron Pharmaceuticals, Inc.

NASDAQ·Biotechnology · Healthcare

$805.02$14.07−1.72%

Market cap$82.88B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About REGN

What companies are REGN's competitors?: Regeneron Pharmaceuticals, Inc. (REGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does REGN compare to its peers?: The peer comparison table on this page shows Regeneron Pharmaceuticals, Inc. (REGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does REGN operate in?: Regeneron Pharmaceuticals, Inc. (REGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

REGN

Regeneron Pharmaceuticals, Inc.

NASDAQ·Biotechnology · Healthcare

$805.02$14.07−1.72%

Market cap$82.88B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


NVSNVSNovartis AG	Novartis AG	$151.12	$287.2B
AZNAZNAstraZeneca PLC	AstraZeneca PLC	$171.49	$266.0B
AMGNAMGNAmgen Inc.	Amgen Inc.	$439.26	$237.5B
GILDGILDGilead Sciences, Inc.	Gilead Sciences, Inc.	$156.04	$193.5B
BIIBBIIBBiogen Inc.	Biogen Inc.	$250.69	$37.0B
GMABGMABGenmab A/S	Genmab A/S	$43.79	$26.9B
IVBXFIVBXFInnovent Biologics, Inc.	Innovent Biologics, Inc.	$11.55	$20.1B
REGMFREGMFRemeGen Co., Ltd.	RemeGen Co., Ltd.	$9.96	$5.6B
OCULOCULOcular Therapeutix, Inc.	Ocular Therapeutix, Inc.	$6.50	$1.4B
EYPTEYPTEyePoint Pharmaceuticals, Inc.	EyePoint Pharmaceuticals, Inc.	$0.40	$33.9M

Frequently Asked Questions About REGN

What companies are REGN's competitors?: Regeneron Pharmaceuticals, Inc. (REGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does REGN compare to its peers?: The peer comparison table on this page shows Regeneron Pharmaceuticals, Inc. (REGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does REGN operate in?: Regeneron Pharmaceuticals, Inc. (REGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.